Abeona Therapeutics (FRA:PCJ) Cyclically Adjusted Book per Share: €29.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PCJ Abeona Therapeutics Inc FRA:PCJ
37 GF Score
Price €5.00
! 5 Warning Signs
View Full Analysis

What is Abeona Therapeutics Cyclically Adjusted Book per Share?

Abeona Therapeutics FRA:PCJ -0.64% 37 Cyclically Adjusted Book per Share is €29.71 as of Jun. 2026. GuruFocus rates FRA:PCJ with a GF Score™ of 37/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Abeona Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was €1.942. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €29.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Abeona Therapeutics's average Cyclically Adjusted Book Growth Rate was -12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Abeona Therapeutics was 46.40% per year. The lowest was -31.70% per year. And the median was 20.70% per year.

As of today (2026-08-19), Abeona Therapeutics's current stock price is €5.004. Abeona Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €29.71. Abeona Therapeutics's Cyclically Adjusted PB Ratio of today is 0.17.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abeona Therapeutics was 0.19. The lowest was 0.10. And the median was 0.13.


Abeona Therapeutics  (FRA:PCJ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abeona Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.004/29.71
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abeona Therapeutics was 0.19. The lowest was 0.10. And the median was 0.13.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Abeona Therapeutics Cyclically Adjusted Book per Share Related Terms


Abeona Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Abeona Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abeona Therapeutics Cyclically Adjusted Book per Share Chart

Abeona Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -289.94 -128.58 -64.34 41.46 35.29

Abeona Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.45 36.18 35.29 31.69 29.71

FRA:PCJ vs RCKT, UPB, PALI: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Abeona Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abeona Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abeona Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abeona Therapeutics's Cyclically Adjusted PB Ratio falls into.


FRA:PCJ
37GF Score
Abeona Therapeutics Inc FRA:PCJ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abeona Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abeona Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.942/333.9520*333.9520
=1.942

Current CPI (Jun. 2026) = 333.9520.

Abeona Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 41.962 241.428 58.043
201612 58.351 241.432 80.712
201703 55.581 243.801 76.133
201706 49.211 244.955 67.090
201709 46.065 246.819 62.327
201712 76.617 246.524 103.789
201803 72.642 249.554 97.209
201806 72.764 251.989 96.432
201809 67.132 252.439 88.809
201812 61.432 251.233 81.659
201903 54.352 254.202 71.404
201906 48.141 256.143 62.765
201909 42.711 256.759 55.552
201912 48.008 256.974 62.389
202003 35.815 258.115 46.338
202006 31.700 257.797 41.064
202009 28.905 260.280 37.087
202012 21.924 260.474 28.109
202103 20.012 264.877 25.231
202106 17.232 271.696 21.181
202109 16.634 274.310 20.251
202112 6.368 278.802 7.628
202203 4.853 287.504 5.637
202206 3.237 296.311 3.648
202209 2.029 296.808 2.283
202212 1.426 296.797 1.605
202303 0.976 301.836 1.080
202306 0.402 305.109 0.440
202309 0.836 307.789 0.907
202312 0.513 306.746 0.558
202403 -0.297 312.332 -0.318
202406 1.633 314.175 1.736
202409 0.950 315.301 1.006
202412 0.921 315.605 0.975
202503 0.782 319.799 0.817
202506 2.767 322.561 2.865
202509 2.784 324.800 2.862
202512 2.470 324.054 2.545
202603 2.205 330.213 2.230
202606 1.942 333.952 1.942

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €29.71 mean?
Abeona Therapeutics (FRA:PCJ) has a Cyclically Adjusted Book per Share of €29.71 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abeona Therapeutics and its competitors.
Is Abeona Therapeutics' Cyclically Adjusted Book per Share too high?
Abeona Therapeutics' current Cyclically Adjusted Book per Share is €29.71. Overall, Abeona Therapeutics has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Abeona Therapeutics' Cyclically Adjusted Book per Share compare to RCKT and UPB?
Abeona Therapeutics' Cyclically Adjusted Book per Share of €29.71 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abeona Therapeutics and its competitors. Abeona Therapeutics's current Cyclically Adjusted Book per Share is €29.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abeona Therapeutics stock overvalued right now?
Abeona Therapeutics (FRA:PCJ) has a current Cyclically Adjusted Book per Share of €29.71. The current Cyclically Adjusted Book per Share is €29.71. Abeona Therapeutics' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Abeona Therapeutics (FRA:PCJ), the current Cyclically Adjusted Book per Share is €29.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abeona Therapeutics Business Description

Other Exchanges ABEO:USA0H7R:UKPCJ:Germany
Address 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, USA, 44103
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
37GF Score

Get the complete analysis for FRA:PCJ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.00
Price